Clinical Trial

Cognitive Impairment Assessment in Breast Cancer Survivors

Name: Cognitive Impairment Assessment in Breast Cancer Survivors — clinical trial record (NCT07582770)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study is a monocentric, observational, cross-sectional study with a case-control design, aimed at evaluating the construct validity, discriminative ability, and diagnostic accuracy of a second-level neuropsychological test battery for the detection of cancer-related cognitive impairment in breast cancer survivors.

Trial Details

NCT Number	NCT07582770
Lead Sponsor	European Institute of Oncology
Conditions	Cancer Related Cognitive Impairment, Breast Cancer Survivors
Enrollment	200 participants
Start Date	2026-05
Primary Completion	2030-04 (estimated)
Study Completion	2030-04 (estimated)
Updated on ClinicalTrials.gov	2026-05-13